Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation

NCT06119802 is registered in ClinicalTrials.gov with Yinglong Hou as lead sponsor.

NCT NCT06119802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06119802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation
Lead sponsor
Yinglong Hou
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
April 30, 2024
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, hyperuricemia